GetTopicDetailResponse(id=a8a09831d3, topicName=Inebilizumab, introduction=Inebilizumab, content=null, image=null, comments=1, allHits=775, url=https://h5.medsci.cn/topic?id=9831, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=94194, tagList=[TagDto(tagId=94194, tagName=Inebilizumab)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2263234, encodeId=e67e2263234e7, content=<a href='/topic/show?id=a8a09831d3' target=_blank style='color:#2F92EE;'>#Inebilizumab#</a> <a href='/topic/show?id=e68c1265e82c' target=_blank style='color:#2F92EE;'>#全身型重癥肌無力#</a>, objectTitle=《新英格蘭雜志》：Inebilizumab治療全身型重癥肌無力的三期臨床試驗, objectType=article, longId=874559, objectId=f3908e4559a9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250220/1740053904413_8538692.png, objectUrl=/article/show_article.do?id=f3908e4559a9, replyNumber=0, likeNumber=27, createdTime=2025-05-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=f3908e4559a9, moduleTitle=《新英格蘭雜志》：Inebilizumab治療全身型重癥肌無力的三期臨床試驗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f3908e4559a9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1954134, encodeId=a4f819541344e, content=<a href='/topic/show?id=a8a09831d3' target=_blank style='color:#2F92EE;'>#Inebilizumab#</a>, objectTitle=Lancet：Inebilizumab可降低視神經(jīng)脊髓炎譜系疾病 (NMOSD)發(fā)作風(fēng)險, objectType=article, longId=179047, objectId=b78a1e90479f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b78a1e90479f, replyNumber=0, likeNumber=85, createdTime=2019-12-22, rootId=0, userName=仁醫(yī)06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b78a1e90479f, moduleTitle=Lancet：Inebilizumab可降低視神經(jīng)脊髓炎譜系疾病 (NMOSD)發(fā)作風(fēng)險, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b78a1e90479f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
